Daniel E. Geffken - 15 Jun 2021 Form 4 Insider Report for WINDTREE THERAPEUTICS INC /DE/ (WINT)

Role
Director
Signature
/s/ John P. Hamill, as Attorney-in-Fact
Issuer symbol
WINT
Transactions as of
15 Jun 2021
Net transactions value
$0
Form type
4
Filing time
17 Jun 2021, 20:02:54 UTC
Next filing
05 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding WINT Common Stock 2,069 15 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WINT Stock Option (Right to Buy) Award $0 +15,000 $0.000000 15,000 15 Jun 2021 Common Stock 15,000 $2.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest in three equal annual installments beginning on the first anniversary of the grant date.